Viemed Healthcare President Sells Over $297,000 in Stock

Michael Moore, the president of Viemed Healthcare, has sold a significant amount of the company's stock in recent transactions.

Mar. 21, 2026 at 12:26pm

Got story updates? Submit your updates here. ›

Viemed Healthcare, Inc. (NASDAQ:VMD) President Michael Moore sold 31,570 shares of the company's stock in a transaction that occurred on Wednesday, March 18th. The shares were sold at an average price of $9.42, for a total value of $297,389.40. Following the transaction, Moore directly owned 1,691,044 shares of the company's stock, valued at $15,929,634.48. This trade represents a 1.83% decrease in his ownership of the stock.

Why it matters

Insider transactions, such as this sale by the Viemed Healthcare president, can provide insights into a company's performance and the confidence of its leadership. The sale of a significant number of shares by a top executive may signal potential concerns or a desire to diversify personal holdings, which could impact investor sentiment.

The details

Michael Moore, the president of Viemed Healthcare, has made several stock sales in recent days. On Wednesday, March 18th, he sold 31,570 shares at an average price of $9.42, totaling $297,389.40. This was followed by additional sales of 65,000 shares on Friday, March 20th at $8.77 per share, and 40,232 shares on Thursday, March 19th at $9.21 per share.

  • On Wednesday, March 18th, Moore sold 31,570 shares.
  • On Friday, March 20th, Moore sold 65,000 shares.
  • On Thursday, March 19th, Moore sold 40,232 shares.

The players

Michael Moore

The president of Viemed Healthcare, Inc. (NASDAQ:VMD).

Viemed Healthcare, Inc.

A provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support.

Got photos? Submit your photos here. ›

The takeaway

The significant stock sales by Viemed Healthcare's president raise questions about the company's performance and the confidence of its leadership. Investors will likely be closely monitoring the company's future developments and any further insider transactions.